UBS Group »

Immuneering Corp - Class A shares owned by UBS Group

Quarter-by-quarter ownership of Immuneering Corp - Class A (IMRX) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Immuneering Corp - Class A

Tip: Access up to 7 years of quarterly data

All positions including Immuneering Corp - Class A held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immuneering Corp - Class A by UBS Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.3M 190k 6.58
2025-09-30 $885k 126k 7.00
2025-06-30 $17k 5.1k 3.37
2025-03-31 $43k 29k 1.52
2024-12-31 $116k 53k 2.20
2024-09-30 $79k 32k 2.49
2024-06-30 $9.0k 7.1k 1.28
2024-03-31 $84k 29k 2.89
2023-03-31 $26k 2.7k 9.71
2022-09-30 $2.0k 105 19.05
2022-06-30 $7.9k 1.4k 5.62
2022-03-31 $21k 3.3k 6.44
2021-12-31 $26k 1.6k 16.05
2021-09-30 $30k 1.1k 26.81